IN2012DN00282A - - Google Patents

Info

Publication number
IN2012DN00282A
IN2012DN00282A IN282DEN2012A IN2012DN00282A IN 2012DN00282 A IN2012DN00282 A IN 2012DN00282A IN 282DEN2012 A IN282DEN2012 A IN 282DEN2012A IN 2012DN00282 A IN2012DN00282 A IN 2012DN00282A
Authority
IN
India
Prior art keywords
breast
compositions
infants
fed infants
nutritional supplement
Prior art date
Application number
Other languages
English (en)
Inventor
Degonda Gabriela Bergonzelli
Isabelle Bureau-Franz
Clara Lucia Garcia-Rodenas
Corinne Magliola
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41259077&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN00282(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN00282A publication Critical patent/IN2012DN00282A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
IN282DEN2012 2009-07-31 2010-07-28 IN2012DN00282A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09166969 2009-07-31
PCT/EP2010/060973 WO2011012655A1 (en) 2009-07-31 2010-07-28 Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients

Publications (1)

Publication Number Publication Date
IN2012DN00282A true IN2012DN00282A (enExample) 2015-05-08

Family

ID=41259077

Family Applications (1)

Application Number Title Priority Date Filing Date
IN282DEN2012 IN2012DN00282A (enExample) 2009-07-31 2010-07-28

Country Status (14)

Country Link
US (1) US20120121562A1 (enExample)
EP (1) EP2459202A1 (enExample)
CN (1) CN102481323A (enExample)
AU (1) AU2010277582A1 (enExample)
BR (1) BR112012002223A2 (enExample)
CA (1) CA2767960A1 (enExample)
CL (1) CL2012000234A1 (enExample)
IN (1) IN2012DN00282A (enExample)
MX (1) MX2012001362A (enExample)
RU (1) RU2012107695A (enExample)
SG (1) SG177541A1 (enExample)
TW (1) TW201117818A (enExample)
WO (1) WO2011012655A1 (enExample)
ZA (1) ZA201201471B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ612455A (en) 2010-12-31 2015-02-27 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
ES2708924T3 (es) 2010-12-31 2019-04-12 Abbott Lab Procedimientos de uso de oligosacáridos de la leche humana para mejorar la salud respiratoria de las vías respiratorias
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
WO2012092159A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
EP3510873A1 (en) 2010-12-31 2019-07-17 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
CN110051676A (zh) 2010-12-31 2019-07-26 雅培制药有限公司 用于调节炎症的人乳寡糖
BR112013016587A2 (pt) 2010-12-31 2016-09-27 Abbott Lab formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas
CN102106463B (zh) * 2011-01-31 2012-12-05 杨永浩 一种微生物饲料添加剂及其制备方法
PH12013501501A1 (en) * 2011-02-10 2019-10-07 Nestec Sa Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
BR112014004772A2 (pt) 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
WO2013057049A1 (en) * 2011-10-18 2013-04-25 Nestec S.A. Composition for use in brain growth and/or cognitive and/or psychomotor development
BR112014008425A2 (pt) 2011-10-18 2017-04-11 Nestec Sa composição para o uso na promoção de angiogênese intestinal e de absorção de nutriente e de tolerância a alimentação enteral e/ou na prevenção e/ou no tratamento de inflamação intestinal e/ou na recuperação após a lesão e a cirurgia intestinal
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
US9987306B2 (en) 2012-10-15 2018-06-05 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
WO2015148384A1 (en) 2014-03-26 2015-10-01 Abbott Laboratories Nutritional supplement powder
WO2015176229A1 (en) * 2014-05-20 2015-11-26 Nestle (China) Ltd. Delivery mode specific synthetic nutritional compositions and nutritional systems comprising them
MX2017010923A (es) * 2015-03-05 2018-01-16 Nestec Sa Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.
EP3294308A4 (en) 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
CN105030843A (zh) * 2015-06-18 2015-11-11 陈英扬 罗伊氏乳杆菌滴剂及其制备方法
AU2016315268B2 (en) * 2015-08-31 2022-12-22 Société des Produits Nestlé S.A. Methods and compositions using Bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances
BR122022001962B1 (pt) * 2015-12-14 2023-05-16 Société des Produits Nestlé S.A. Composição nutricional sintética, seu uso, e derivado de ácido graxo
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
US10912323B2 (en) 2016-02-29 2021-02-09 Abbott Laboratories Nutritional supplement powder
KR101938865B1 (ko) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
EP3629770A1 (en) * 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
EP3645023B1 (en) * 2017-06-30 2022-09-14 N.V. Nutricia Synbiotic composition for preventing hyperinsulinemia and insulin resistance
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
CN108823125A (zh) * 2018-06-13 2018-11-16 山东巴元生物科技有限公司 一种治疗睡眠障碍益生菌制剂的生产方法及应用
US20210298328A1 (en) * 2018-08-08 2021-09-30 Mars, Incoroprated Pet food products comprising oligosaccharides and methods of use
EP3897678A1 (en) * 2018-12-21 2021-10-27 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
US20210352925A1 (en) * 2019-02-04 2021-11-18 N.V. Nutricia Fermented formula with non digestible oligosaccharides for sleep improvement
KR102188765B1 (ko) * 2019-06-12 2020-12-08 정옥숙 애완동물용 동결건조파우더 및 이의 제조방법
WO2021105353A1 (en) * 2019-11-29 2021-06-03 Société des Produits Nestlé S.A. Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis
CN112868800A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 含母乳低聚糖提高免疫力的婴幼儿配方奶粉及其制备方法
US20250228809A1 (en) * 2021-09-28 2025-07-17 Societe Des Produits Nestle S.A. Compositions for use
US20250228282A1 (en) * 2024-01-12 2025-07-17 Nutifood Nutrition Food Joint Stock Company Supplementary composition containing 2'-fucosyllactose (2'-fl) and fructo-oligosaccharide (fos) with synergistic effects on the digestive and immune systems for children, and process of manufacturing a children formula containing said supplementary composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3936799C1 (enExample) * 1989-11-04 1991-01-10 Deutsche Atochem Werke Gmbh, 5300 Bonn, De
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
CA2458936A1 (en) * 2001-08-31 2003-03-13 Nutricopia, Inc. Nutritional frozen dessert and methods of menufacture
EP1638414B1 (en) * 2003-06-23 2009-06-17 Nestec S.A. Infant or follow-on formula
PL1638415T3 (pl) * 2003-06-23 2011-05-31 Nestec Sa Preparat dla niemowląt lub preparat pochodny
AU2004279621A1 (en) * 2003-10-14 2005-04-21 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
PL2805625T5 (pl) * 2005-02-28 2023-03-13 N.V. Nutricia Kompozycja odżywcza z prebiotykami i probiotykami
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US20070059297A1 (en) * 2005-08-04 2007-03-15 Nestec, S.A. Methods and compositions for improving visual acuity
ES2334943T3 (es) * 2005-10-05 2010-03-17 Nestec S.A. Uso de una formulacion nutritiva para fomentar la recuperacion del crecimiento.
PL2004201T3 (pl) * 2006-03-29 2019-02-28 Nestec S.A. Suplementy diety zawierające probiotyki
US7374924B2 (en) 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
WO2009079544A1 (en) * 2007-12-17 2009-06-25 University Of Florida Research Foundation, Inc. Materials and methods for treatment of pathological ocular vascular proliferation
AU2009293475A1 (en) * 2008-09-19 2010-03-25 Nestec S.A. Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment

Also Published As

Publication number Publication date
BR112012002223A2 (pt) 2016-06-07
AU2010277582A1 (en) 2012-02-02
ZA201201471B (en) 2014-08-27
CN102481323A (zh) 2012-05-30
CL2012000234A1 (es) 2012-09-28
US20120121562A1 (en) 2012-05-17
RU2012107695A (ru) 2013-09-10
SG177541A1 (en) 2012-02-28
CA2767960A1 (en) 2011-02-03
MX2012001362A (es) 2012-02-22
TW201117818A (en) 2011-06-01
WO2011012655A1 (en) 2011-02-03
EP2459202A1 (en) 2012-06-06

Similar Documents

Publication Publication Date Title
IN2012DN00282A (enExample)
MY164674A (en) Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
MX2022004262A (es) Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.
PH12012502318A1 (en) Substantially clear nutritional liquids comprising calcium hmb and soluble protein
MY173382A (en) Infant feeding formulas comprising probiotic micro-organisms
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
IN2014CN04773A (enExample)
MY161548A (en) Nutritional supplements for 50+individuals for improving vitality, immunity, eye and bone health
IN2012DN00713A (enExample)
PH12013500739A1 (en) Array of age-tailored nutritional formula with probiotics
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
PH12013500716A1 (en) Age-tailored nutritional composition with animal fats and vegetable fats
MX2015008583A (es) Composiciones nutricionales que contienen treonato de magnesio y usos de las mismas.
MY175195A (en) Nutritional compositions
MX2013012136A (es) Composiciones que comprenden un antimetabolito de glucosa y selenio.
NZ612586A (en) Food containing milk ceramide, and process for production thereof
PH12018500988A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
SG149718A1 (en) Cordyceps extract as a dietary supplement and uses thereof
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
MX346623B (es) Composicones a base de arcilla y polen de abeja, su proceso de preparacion y su uso nutricional y terapeutico.
PT2477503E (pt) Processo de preparação de um produto lácteo pasteurizado e fermentado, suplementado com cálcio e vitamina d
PH12018500924A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
PH12018500890A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
MX2018006290A (es) Composiciones nutritivas y formulas infantiles para promover la mielinizacion en el cerebro.
CN105454817A (zh) 一种补钙食品